Savara (SVRA) Return on Capital Employed Growth (1y) (2012 - 2026)
Savara (SVRA) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 2,400.00 |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | -271.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -271.00 |
| Dec 31, 2025 | -2,101.00 |
| Sep 30, 2025 | -3,866.00 |
| Jun 30, 2025 | -1,300.00 |
| Mar 31, 2025 | -1,319.00 |
| Dec 31, 2024 | -1,342.00 |
| Sep 30, 2024 | -1,330.00 |
| Jun 30, 2024 | -2,054.00 |
| Mar 31, 2024 | -1,141.00 |
| Dec 31, 2023 | -730.00 |
| Sep 30, 2023 | -1,126.00 |
| Jun 30, 2023 | -1,442.00 |
| Mar 31, 2023 | -788.00 |
| Dec 31, 2022 | -337.00 |
| Sep 30, 2022 | -204.00 |
| Jun 30, 2022 | -137.00 |
| Mar 31, 2022 | 467.00 |
| Dec 31, 2021 | 2,690.00 |
| Sep 30, 2021 | 4,061.00 |
| Jun 30, 2021 | 3,977.00 |